Laurence M. Corash's Insider Trades & SAST Disclosures
Laurence M. Corash's most recent trade in Cerus Corp. was a trade of 16,666 Common Stock done . Disclosure was reported to the exchange on March 12, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Laurence M. Corash.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2024 | 16,666 | 2,368,167 (1%) | 0% | - | Common Stock | |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2024 | 16,666 | 0 | - | - | Restricted Stock Unit | |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 1.97 per share. | 12 Mar 2024 | 14,360 | 2,339,740 (1%) | 0% | 2.0 | 28,352 | Common Stock |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 2.06 per share. | 12 Mar 2024 | 14,067 | 2,354,100 (1%) | 0% | 2.1 | 28,936 | Common Stock |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 90,000 | 2,351,501 | - | 0 | Restricted Stock Unit | |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2023 | 23,460 | 0 | - | - | Restricted Stock Unit | |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2023 | 23,460 | 2,260,176 (1%) | 0% | - | Common Stock | |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2023 | 16,667 | 2,267,246 (1%) | 0% | - | Common Stock | |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2023 | 16,667 | 16,666 | - | - | Restricted Stock Unit | |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 2.80 per share. | 12 Mar 2023 | 9,597 | 2,250,579 (1%) | 0% | 2.8 | 26,872 | Common Stock |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 2.80 per share. | 12 Mar 2023 | 5,745 | 2,261,501 (1%) | 0% | 2.8 | 16,086 | Common Stock |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 110,000 | 2,236,716 | - | 0 | Restricted Stock Unit | |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2022 | 45,000 | 2,117,586 (1%) | 0% | - | Common Stock | |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2022 | 45,000 | 0 | - | - | Restricted Stock Unit | |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2022 | 22,770 | 2,124,204 (1%) | 0% | - | Common Stock | |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2022 | 22,770 | 23,460 | - | - | Restricted Stock Unit | |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2022 | 16,667 | 33,333 | - | - | Restricted Stock Unit | |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2022 | 16,667 | 2,132,698 (1%) | 0% | - | Common Stock | |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 5.04 per share. | 12 Mar 2022 | 16,152 | 2,101,434 (1%) | 0% | 5.0 | 81,400 | Common Stock |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 5.04 per share. | 12 Mar 2022 | 8,173 | 2,116,031 (1%) | 0% | 5.0 | 41,189 | Common Stock |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 5.04 per share. | 12 Mar 2022 | 5,982 | 2,126,716 (1%) | 0% | 5.0 | 30,147 | Common Stock |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 90,000 | 90,000 | - | - | Option (Right to Buy) | |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 45,000 | 2,072,586 | - | 0 | Restricted Stock Unit | |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2021 | 40,000 | 5,000 | - | - | Option (Right to Buy) | |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.75 per share. | 13 Dec 2021 | 40,000 | 2,022,586 (1%) | 0% | 3.8 | 150,000 | Common Stock |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2021 | 25,200 | 0 | - | - | Option (Right to Buy) | |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.66 per share. | 30 Apr 2021 | 25,200 | 1,982,586 (1%) | 0% | 3.7 | 92,232 | Common Stock |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2021 | 45,000 | 45,000 | - | - | Restricted Stock Unit | |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2021 | 45,000 | 1,958,391 (1%) | 0% | - | Common Stock | |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2021 | 22,770 | 1,965,375 (1%) | 0% | - | Common Stock | |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2021 | 22,770 | 46,230 | - | - | Restricted Stock Unit | |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2021 | 15,833 | 1,913,391 (1%) | 0% | - | Common Stock | |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2021 | 15,833 | 0 | - | - | Restricted Stock Unit | |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 6.38 per share. | 12 Mar 2021 | 15,786 | 1,942,605 (1%) | 0% | 6.4 | 100,678 | Common Stock |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 6.38 per share. | 12 Mar 2021 | 7,989 | 1,957,386 (1%) | 0% | 6.4 | 50,951 | Common Stock |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 100,000 | 100,000 | - | - | Option (Right to Buy) | |
| Cerus Corp. | Laurence M. Corash | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 50,000 | 50,000 | - | - | Restricted Stock Unit |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges